Kairos Pharma, LTD.·4

Nov 25, 8:30 PM ET

Murali Ramachandran 4

4 · Kairos Pharma, LTD. · Filed Nov 25, 2024

Insider Transaction Report

Form 4
Period: 2024-11-25
Murali Ramachandran
VP of Research and Development
Transactions
  • Purchase

    COMMON STOCK

    2024-11-25$1.59/sh+200$318133,057 total

Documents

1 file
  • 4
    ownership.xmlPrimary